Skip to content

Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05991960
Enrollment
96
Registered
2023-08-15
Start date
2023-09-11
Completion date
2023-12-04
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts

Brief summary

Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.

Interventions

DEVICEIntervention

No study treatments will be administered during this retrospective study. However, data will be collected from medical records of patients who have been treated with the subject device of this study.

Sponsors

Johnson & Johnson Surgical Vision, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Previously bilaterally implanted with TECNIS Odyssey IOL, following cataract extraction; 2. Enrollment at least 21 days after second eye surgery; 3. Clear intraocular media in each eye. 4. Signed consent and data protection documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.

Exclusion criteria

1. Concurrent participation in an interventional clinical trial during the time from which the data will be collected; 2. Use of systemic or ocular medication that may affect vision; 3. Prior corneal refractive surgery in each eye (i.e., LASIK, PRK, SMILE, RK, CK); NOTE: Limbal relaxing incisions (LRI) are permissible as planned at the time of surgery (intraoperatively) but not postoperatively within the retrospective analysis window; 4. Ongoing adverse events in each eye that might impact outcomes during the study visit as determined by the investigator; 5. Acute or chronic disease or condition, ocular trauma or surgery that may affect vision in each eye (e.g., clinically significant macular degeneration, glaucoma, cystoid macular edema, proliferative diabetic retinopathy, keratoconus etc.). 6. Amblyopia, strabismus, nystagmus in each eye.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity1-month postoperativeVisual Acuity will be collected via observed case data in units of logMAR.
Manifest Refraction1-month postoperativeManifest Refraction will be collected via observed case data in units of diopters.
Visual Symptoms/Complaints1-month postoperativeVisual Symptoms/Complaints will be measured using a questionnaire on a 5-point scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026